A citation-based method for searching scientific literature

H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
Times Cited: 128

List of co-cited articles
523 articles co-cited >1

Times Cited
  Times     Co-cited

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996

Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994

Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995

Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997

Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997

Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997

Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999

A descriptive study of BRCA1 testing and reactions to disclosure of test results.
H T Lynch, S J Lemon, C Durham, S T Tinley, C Connolly, J F Lynch, J Surdam, E Orinion, S Slominski-Caster, P Watson,[...]. Cancer 1997

Attitudes towards cancer predictive testing and transmission of information to the family.
C Julian-Reynier, F Eisinger, P Vennin, F Chabal, Y Aurran, C Noguès, Y J Bignon, M Machelard-Roumagnac, C Maugard-Louboutin, D Serin,[...]. J Med Genet 1996

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994

Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999

Hereditary cancer risk notification and testing: how interested is the general population?
M A Andrykowski, R Lightner, J L Studts, R K Munn. J Clin Oncol 1997

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.
R Wooster, S L Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, K Nguyen, S Seal, T Tran, D Averill. Science 1994

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
F J Couch, M L DeShano, M A Blackwood, K Calzone, J Stopfer, L Campeau, A Ganguly, T Rebbeck, B L Weber. N Engl J Med 1997

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997

Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
W Burke, M Daly, J Garber, J Botkin, M J Kahn, P Lynch, A McTiernan, K Offit, J Perlman, G Petersen,[...]. JAMA 1997

Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?
J Audrain, B Rimer, D Cella, J Garber, B N Peshkin, J Ellis, J Schildkraut, M Stefanek, V Vogel, C Lerman. J Clin Oncol 1998

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979

Psychological side effects of breast cancer screening.
C Lerman, B Trock, B K Rimer, C Jepson, D Brody, A Boyce. Health Psychol 1991

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000

Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995

Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999

Mammography adherence and psychological distress among women at risk for breast cancer.
C Lerman, M Daly, C Sands, A Balshem, E Lustbader, T Heggan, L Goldstein, J James, P Engstrom. J Natl Cancer Inst 1993

Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.
G Geller, J R Botkin, M J Green, N Press, B B Biesecker, B Wilfond, G Grana, M B Daly, K Schneider, M J Kahn. JAMA 1997

Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995

Attitudes toward genetic testing for colon cancer risk.
K R Smith, R T Croyle. Am J Public Health 1995

Awareness and attitudes concerning BRCA gene testing.
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
T S Frank, S A Manley, O I Olopade, S Cummings, J E Garber, B Bernhardt, K Antman, D Russo, M E Wood, L Mullineau,[...]. J Clin Oncol 1998

A transcript map of the newly defined 165 kb Wolf-Hirschhorn syndrome critical region.
T J Wright, D O Ricke, K Denison, S Abmayr, P D Cotter, K Hirschhorn, M Keinänen, D McDonald-McGinn, M Somer, N Spinner,[...]. Hum Mol Genet 1997

Pitt-Rogers-Danks syndrome and Wolf-Hirschhorn syndrome are caused by a deletion in the same region on chromosome 4p 16.3.
S G Kant, A Van Haeringen, E Bakker, I Stec, D Donnai, P Mollevanger, G C Beverstock, M C Lindeman-Kusse, G J Van Ommen. J Med Genet 1997

A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
S C Daw, C Taylor, M Kraman, K Call, J Mao, S Schuffenhauer, T Meitinger, T Lipson, J Goodship, P Scambler. Nat Genet 1996

Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis.
D A Driscoll, J Salvin, B Sellinger, M L Budarf, D M McDonald-McGinn, E H Zackai, B S Emanuel. J Med Genet 1993

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.